These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21068439)

  • 21. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B.
    Cappellen D; Luong-Nguyen NH; Bongiovanni S; Grenet O; Wanke C; Susa M
    J Biol Chem; 2002 Jun; 277(24):21971-82. PubMed ID: 11923298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue.
    Alwood JS; Shahnazari M; Chicana B; Schreurs AS; Kumar A; Bartolini A; Shirazi-Fard Y; Globus RK
    J Interferon Cytokine Res; 2015 Jun; 35(6):480-7. PubMed ID: 25734366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking.
    Nojiri H; Saita Y; Morikawa D; Kobayashi K; Tsuda C; Miyazaki T; Saito M; Marumo K; Yonezawa I; Kaneko K; Shirasawa T; Shimizu T
    J Bone Miner Res; 2011 Nov; 26(11):2682-94. PubMed ID: 22025246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SHP-2 regulates growth factor dependent vascular signalling and function.
    Mannell H; Krotz F
    Mini Rev Med Chem; 2014; 14(6):471-83. PubMed ID: 22512561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms/PI3K/Akt/NF-κB pathway in osteoclasts.
    Kalbasi Anaraki P; Patecki M; Tkachuk S; Kiyan Y; Haller H; Dumler I
    J Bone Miner Res; 2015 Feb; 30(2):379-88. PubMed ID: 25196912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.
    Kittaka M; Mayahara K; Mukai T; Yoshimoto T; Yoshitaka T; Gorski JP; Ueki Y
    J Bone Miner Res; 2018 Jan; 33(1):167-181. PubMed ID: 28914985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells.
    Schubbert S; Lieuw K; Rowe SL; Lee CM; Li X; Loh ML; Clapp DW; Shannon KM
    Blood; 2005 Jul; 106(1):311-7. PubMed ID: 15761018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of pro-B cell lines from motheaten mutant mouse defective in SHP-1 protein tyrosine phosphatase.
    Miyamoto A; Kunisada T; Yamazaki H; Miyake K; Nishikawa SI; Sudo T; Shultz LD; Hayashi SI
    Immunol Lett; 1998 Sep; 63(2):75-82. PubMed ID: 9761368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.
    Inui M; Kikuchi Y; Aoki N; Endo S; Maeda T; Sugahara-Tobinai A; Fujimura S; Nakamura A; Kumanogoh A; Colonna M; Takai T
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4816-21. PubMed ID: 19251634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo.
    Kim HJ; Zhang K; Zhang L; Ross FP; Teitelbaum SL; Faccio R
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2325-30. PubMed ID: 19171907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SHP-2 Phosphatase Prevents Colonic Inflammation by Controlling Secretory Cell Differentiation and Maintaining Host-Microbiota Homeostasis.
    Coulombe G; Langlois A; De Palma G; Langlois MJ; McCarville JL; Gagné-Sanfaçon J; Perreault N; Feng GS; Bercik P; Boudreau F; Verdu EF; Rivard N
    J Cell Physiol; 2016 Nov; 231(11):2529-40. PubMed ID: 27100271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival.
    Chen J; Yu WM; Bunting KD; Qu CK
    Oncogene; 2004 Apr; 23(20):3659-69. PubMed ID: 15116097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice.
    Hayashi S; Tsuneto M; Yamada T; Nose M; Yoshino M; Shultz LD; Yamazaki H
    Endocrinology; 2004 Jun; 145(6):2721-9. PubMed ID: 14988381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.
    Chaisson ML; Branstetter DG; Derry JM; Armstrong AP; Tometsko ME; Takeda K; Akira S; Dougall WC
    J Biol Chem; 2004 Dec; 279(52):54841-8. PubMed ID: 15485831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1.
    Chen HE; Chang S; Trub T; Neel BG
    Mol Cell Biol; 1996 Jul; 16(7):3685-97. PubMed ID: 8668185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into monocyte-driven osteoclastogenesis and its link with hematopoiesis: regulatory roles of PECAM-1 (CD31) and SHP-1.
    Wu Y; Madri J
    Crit Rev Immunol; 2010; 30(5):423-33. PubMed ID: 21083524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EZH2 deletion in early mesenchyme compromises postnatal bone microarchitecture and structural integrity and accelerates remodeling.
    Hemming S; Cakouros D; Codrington J; Vandyke K; Arthur A; Zannettino A; Gronthos S
    FASEB J; 2017 Mar; 31(3):1011-1027. PubMed ID: 27934660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.